Plain-English translation of NCT07058012 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing , an immune-boosting medication that helps your body's own immune system fight cancer cells. You'll receive this medication alone or combined with other newer immune drugs. The goal is to see if these treatments can prevent colorectal cancer from returning in patients who have already had surgery and chemotherapy but still show traces of cancer in their blood.
Even after surgery and chemotherapy, some colorectal cancer patients have tiny amounts of cancer remaining that can lead to the disease coming back. This medication works differently than traditional chemotherapy by training the immune system to recognize and destroy cancer cells, and researchers want to know if it can stop cancer from recurring.
You likely qualify if…
You likely don't qualify if…
You will be assigned to receive the medication either alone or in combination with one other immune-boosting drug, given as infusions at the hospital or clinic. You'll have regular blood tests and imaging scans to monitor how well the treatment is working and watch for side effects. The trial will track whether the medication prevents your cancer from returning over time.
AI-generated summary from trial data · Aug 2, 2026 · Not medical advice
United States